We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $3.64B
1-Year Est. Return 83.38%
This Fund
S&P 500
This Quarter Est. Return
+49.74%
1 Year Est. Return
+83.38%
3 Year Est. Return
+239.61%
5 Year Est. Return
+330.19%
10 Year Est. Return
+1,383.86%
AUM
$3.64B
AUM Growth
+$913M
Cap. Flow
+$245M
Cap. Flow %
6.73%
Top 10 Hldgs %
40.93%
Holding
1,250
New
158
Increased
429
Reduced
585
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$72.2M
2
AVGO icon
Broadcom
AVGO
+$27.9M
3
SNDK
Sandisk
SNDK
+$15M
4
AAPL icon
Apple
AAPL
+$13.9M
5
MU icon
Micron Technology
MU
+$12.9M

Top Sells

Rank Stock Value
1
HON icon
Honeywell
HON
+$5.34M
2
APLS
Apellis Pharmaceuticals
APLS
+$3.27M
3
AEM icon
Agnico Eagle Mines
AEM
+$2.54M
4
NEM icon
Newmont
NEM
+$2.3M
5
FOLD
Amicus Therapeutics
FOLD
+$2.06M

Sector Composition

Rank Sector Weight
1 Technology 56.05%
2 Healthcare 8.58%
3 Communication Services 8.31%
4 Consumer Discretionary 7.81%
5 Industrials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
276
3M
MMM
$86.9B
$1.45M 0.04%
8,959
-11
-0.1% -$1.67K
VCYT icon
277
Veracyte
VCYT
$3.42B
$1.45M 0.04%
24,694
-24,080
-49% -$1.01M
ONTO icon
278
Onto Innovation
ONTO
$13.2B
$1.43M 0.04%
3,778
+533
+16% +$151K
SW
279
Smurfit Westrock
SW
$24B
$1.41M 0.04%
30,577
+15,591
+104% +$644K
IMVT icon
280
Immunovant
IMVT
$8.11B
$1.41M 0.04%
36,510
-24,498
-40% -$746K
GRAL
281
GRAIL Inc
GRAL
$3.59B
$1.37M 0.04%
20,078
-4,710
-19% -$277K
NTLA icon
282
Intellia Therapeutics
NTLA
$1.79B
$1.36M 0.04%
80,427
-8,628
-10% -$121K
HSBC icon
283
HSBC
HSBC
$367B
$1.35M 0.04%
14,181
-409
-3% -$37.3K
BCRX icon
284
BioCryst Pharmaceuticals
BCRX
$2.55B
$1.34M 0.04%
134,034
-24,428
-15% -$221K
TPL icon
285
Texas Pacific Land
TPL
$25B
$1.34M 0.04%
3,061
+321
+12% +$130K
DHR icon
286
Danaher
DHR
$146B
$1.34M 0.04%
7,015
-17
-0.2% -$3.09K
VRT icon
287
Vertiv
VRT
$108B
$1.33M 0.04%
3,967
+126
+3% +$40K
OMC icon
288
Omnicom Group
OMC
$22.7B
$1.32M 0.04%
18,154
+5,025
+38% +$378K
INFY icon
289
Infosys
INFY
$47.4B
$1.31M 0.04%
124,875
+6,987
+6% +$87.5K
TNGX icon
290
Tango Therapeutics
TNGX
$3.8B
$1.31M 0.04%
41,889
-5,846
-12% -$145K
DYN icon
291
Dyne Therapeutics
DYN
$4.53B
$1.31M 0.04%
58,810
-23,328
-28% -$434K
ZTO icon
292
ZTO Express
ZTO
$15.9B
$1.29M 0.04%
57,798
-59
-0.1% -$1.41K
DNLI icon
293
Denali Therapeutics
DNLI
$3.56B
$1.28M 0.04%
49,899
-18,328
-27% -$377K
ED icon
294
Consolidated Edison
ED
$39.7B
$1.28M 0.04%
11,540
-776
-6% -$84.4K
PLD icon
295
Prologis
PLD
$131B
$1.27M 0.04%
9,411
+36
+0.4% +$5.1K
PEG icon
296
Public Service Enterprise Group
PEG
$36.7B
$1.27M 0.03%
15,603
-1,426
-8% -$114K
SCHW
297
Charles Schwab
SCHW
$189B
$1.26M 0.03%
13,700
-697
-5% -$63.6K
BEKE icon
298
KE Holdings
BEKE
$19.8B
$1.25M 0.03%
86,289
+1,775
+2% +$29.2K
AMX icon
299
America Movil
AMX
$68.9B
$1.25M 0.03%
48,042
-11,432
-19% -$300K
PH icon
300
Parker-Hannifin
PH
$121B
$1.24M 0.03%
1,267
+35
+3% +$32.1K
10 11
12
13 14

Similar funds

VGM
Voyager Global Management New York $3.63B AUM 5.73% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.65B AUM 41.77% 1-Year Est. Return
CC
Carrhae Capital London, United Kingdom $3.62B AUM 34.35% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $3.66B AUM 32.08% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Profund Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Profund Advisors held 1,250 positions worth $3.64B, up 34% from $2.72B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors deployed $245M of net new capital in Q2 2026, opening 158 new positions and adding to 429 existing holdings. Its largest new stake was Honeywell Aerospace: 24,902 shares worth $5.51M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 43% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Honeywell, an estimated $5.34M trimmed.

  • Profund Advisors's largest Q2 2026 buy was Honeywell Aerospace: 24,902 shares worth $5.51M.
  • Profund Advisors added most to NVIDIA in Q2 2026, an estimated $72.2M increase.
  • Profund Advisors's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.34M.
  • Profund Advisors fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $3.27M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.64B portfolio in Q2 2026.
  • Profund Advisors opened 158 new positions and closed 75 in Q2 2026.
  • Profund Advisors's portfolio value rose 34% quarter-over-quarter to $3.64B.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.